Literature DB >> 19522710

Prevalence of myocardial infarction in patients with psoriasis in central China.

J Xiao1, L-H Chen, Y-T Tu, X-H Deng, J Tao.   

Abstract

OBJECTIVE: To explore whether the prevalence of myocardial infarction (MI) was higher in psoriatics than in patients without psoriasis, and whether major cardiovascular risk factors were associated with psoriasis in central China.
METHODS: Data were collected at Medical Records Section of Affiliated Union Hospital, Tongji Hospital, Wuhan Iron and Steel Company General Hospital and No. 1 Hospital of Wuhan between 1999 and 2007. Patients with psoriasis were classified as severe if they ever received a systemic therapy. And patients were classified as having risk factors if they received codes for diabetes, hypertension, hyperlipidemia, or smoking. Controls without psoriasis were randomly selected from the Physical Examination Centre in the Affiliated Union Hospital. Analysis was performed by using conditional logistic regression, and adjustments were made for age and sex.
RESULTS: There were 45 MIs (2.96%) within the control population and 97 (6.00%) and 118 (8.01%) MIs within the mild and severe psoriasis groups, respectively. Respective odds ratio (OR) and 95% confidence interval (95% CI) of cardiovascular risk factors in those with mild psoriasis than controls were as follows: obesity (OR, 1.41; 95% CI, 1.08-1.85), diabetes (OR, 1.45; 95% CI, 1.11-1.91), hypertension (OR, 1.39; 95% CI, 1.04-1.85), hyperlipidemia (OR, 1.37; 95% CI, 1.06-1.78) and smoking (OR, 1.35; 95% CI, 1.01-1.80). Patients with severe psoriasis had higher adjusted odds of obesity (OR, 1.51; 95% CI, 1.15-1.98), diabetes (OR, 1.69; 95% CI, 1.32-2.17), hypertension (OR, 1.41; 95% CI, 1.06-1.88), hyperlipidemia (OR, 1.43; 95% CI, 1.11-1.84), and smoking (OR, 1.57; 95% CI, 1.20-2.05) than patients with mild psoriasis and controls. After adjusting for systemic therapies and cardiovascular risk factors (obesity, diabetes, hypertension, hyperlipidemia and smoking) in addition to age and sex, for patients with mild or severe psoriasis, the OR of having an MI was 1.72 (95% CI, 1.29-2.30) and 2.01 (95% CI, 1.45-2.79), respectively.
CONCLUSIONS: The prevalence of MI is higher in mild and severe psoriasis than in patients without psoriasis in central China. In addition, MI and major cardiovascular risk factors (e.g. diabetes, hypertension, hyperlipidemia and smoking) are associated with psoriasis in central China.

Entities:  

Mesh:

Year:  2009        PMID: 19522710     DOI: 10.1111/j.1468-3083.2009.03318.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  17 in total

1.  Psoriasis and cardiovascular risk: strength in numbers, part II.

Authors:  Joel M Gelfand; Nehal N Mehta; Sinéad M Langan
Journal:  J Invest Dermatol       Date:  2011-05       Impact factor: 8.551

2.  Genetic Epidemiology of Psoriasis.

Authors:  Rashmi Gupta; Maya G Debbaneh; Wilson Liao
Journal:  Curr Dermatol Rep       Date:  2014-03

Review 3.  Managing cardiovascular risk in patients with chronic inflammatory diseases.

Authors:  Boulos Haraoui; Peter P Liu; Kim A Papp
Journal:  Clin Rheumatol       Date:  2012-01-14       Impact factor: 2.980

4.  Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis.

Authors:  Rahat S Azfar; Nicole M Seminara; Daniel B Shin; Andrea B Troxel; David J Margolis; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2012-09

5.  Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study.

Authors:  H Maradit-Kremers; M Icen; F C Ernste; R A Dierkhising; M T McEvoy
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-03       Impact factor: 6.166

Review 6.  Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature.

Authors:  Rita V Patel; Michael L Shelling; Srdjan Prodanovich; Daniel G Federman; Robert S Kirsner
Journal:  J Gen Intern Med       Date:  2011-04-07       Impact factor: 5.128

7.  Metabolic syndrome in patients with psoriatic disease.

Authors:  Joel M Gelfand; Howa Yeung
Journal:  J Rheumatol Suppl       Date:  2012-07

8.  Association between Psoriasis and Cardiovascular Risk Factors in Korean Patients.

Authors:  Woo Jin Choi; Eun Joo Park; In Ho Kwon; Kwang Ho Kim; Kwang Joong Kim
Journal:  Ann Dermatol       Date:  2010-08-05       Impact factor: 1.444

9.  Increased risk of olfactory and taste dysfunction in the United States psoriasis population.

Authors:  Pei-Xun Zhong; Yi-Hsien Chen; I-Hsun Li; Yuan-Liang Wen; Hui-Han Kao; Kuan-Wei Chiang; Li-Ting Kao
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-05       Impact factor: 2.503

10.  Incidence of Pulmonary Arterial Hypertension in Patients with Psoriasis: A Retrospective Cohort Study.

Authors:  Young M Choi; Shannon Famenini; Jashin J Wu
Journal:  Perm J       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.